William G. Harris's most recent trade in Soleno Therapeutics Inc was a trade of 6,500 Common Stock done . Disclosure was reported to the exchange on June 6, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 6,500 | 15,401 (0%) | 0% | 0 | Common Stock | |
Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 10,000 | 10,000 | - | - | Stock option (right to buy) | |
Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 2,666 | 2,666 | - | - | Stock option (right to buy) | |
Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 2,666 | 2,666 | - | - | Stock option (right to buy) | |
Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 42,254 | 146,870 (0%) | 0% | 0 | Common Stock | |
Soleno Therapeutics Inc | William G. Harris | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.36 per share. | 31 Jan 2022 | 13,352 | 133,518 (0%) | 0% | 0.4 | 4,740 | Common Stock |
Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 20,167 | 110,989 (0%) | 0% | 0 | Common Stock | |
Soleno Therapeutics Inc | William G. Harris | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.74 per share. | 29 Oct 2021 | 6,373 | 104,616 (0%) | 0% | 0.7 | 4,740 | Common Stock |
Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 16,484 | 96,032 (0%) | 0% | 0 | Common Stock | |
Soleno Therapeutics Inc | William G. Harris | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.91 per share. | 30 Jul 2021 | 5,210 | 90,822 (0%) | 0% | 0.9 | 4,741 | Common Stock |
Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 31,862 | 31,862 | - | - | Employee stock option (right to buy) | |
Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 12,397 | 83,466 (0%) | 0% | 0 | Common Stock | |
Soleno Therapeutics Inc | William G. Harris | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.21 per share. | 30 Apr 2021 | 3,918 | 79,548 (0%) | 0% | 1.2 | 4,741 | Common Stock |
First US Bancshares Inc | William G. Harrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 18 | 5,839 | - | - | Phantom Stock Units | |
First US Bancshares Inc | William G. Harrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 50 | 57,369 (0%) | 0% | 0 | Common Stock, $.01 par value | |
Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 7,015 | 73,286 (0%) | 0% | 0 | Common Stock | |
Soleno Therapeutics Inc | William G. Harris | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.96 per share. | 29 Jan 2021 | 2,217 | 71,069 (0%) | 0% | 2.0 | 4,345 | Common Stock |
Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2021 | 40,000 | 161,932 | - | - | Employee stock option (right to buy) | |
Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2020 | 7,902 | 68,768 (0%) | 0% | 0 | Common Stock | |
Soleno Therapeutics Inc | William G. Harris | Director | Sale of securities on an exchange or to another person at price $ 1.74 per share. | 30 Oct 2020 | 2,497 | 66,271 (0%) | 0% | 1.7 | 4,345 | Common Stock |
First US Bancshares Inc | William G. Harrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 26 | 5,801 | - | - | Phantom Stock Units | |
Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 1.72 per share. | 31 Jul 2020 | 5,469 | 5,469 (0%) | 0% | 1.7 | 9,407 | Common Stock |
First US Bancshares Inc | William G. Harrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 24 | 5,775 | - | - | Phantom Stock Units |